RANZCR 2025: Medical specialists converge to examine Australian radiotherapy breakthrough
Australian researchers last night revealed human clinical data for a world-first pan-cancer biomarker assay, RadnostTM,…
Browsing: Featured
Wearable patch for early skin cancer detection developed
Researchers at Wake Forest University School of Medicine, USA, have developed a ground-breaking, battery-free wearable patch…
Consistency is the key: regular moderate exercise linked to lower digestive system cancer risk and mortality
Digestive system cancers (DSCs)—encompassing cancers of the digestive tract (mouth, throat, oesophagus, stomach, small intestine,…
Hormonal contraceptive use and breast cancer risk
A recent cohort study of more than 2 million adolescent girls and women has provided…
S3E8 The Oncology Journal Club: ESMO 2025 Special Part 1
Are you ready for ESMO Bingo? Welcome to Episode 8 of the third series of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson to unpack ESMO 2025
What is the extent of disparities in cancer clinical trials among low- and middle-income countries?
New research reveals that the number and complexity of cancer clinical trials since 2001 have…
ESMO 2025: Thymic health linked to immunotherapy response
The health of the thymus – a key part of the body’s immune system -…
ESMO 2025: Men with BRCA1 and BRCA2 gene mutations should get annual prostate cancer screening
Scientists at The Institute of Cancer Research, London, are calling for targeted screening after finding…
ESMO 2025: New generation of antibody-drug conjugates shows promise in early-stage disease
The ESMO Congress 2025 has seen pivotal studies unveiling compelling evidence that a new class of…
ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer
Results from a trial presented at ESMO 205 have shown that a targeted therapy combination improved…